Renalytix plc SEC filings RENXF
Renalytix plc has 233 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 30, 2024 for the period ended Jun 30, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 19, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Jan 16, 2025 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 23, 2026 | — |
| F-6 POS | Filing | Dec 3, 2025 | — |
| F-6 POS | Filing | Sep 4, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| 424B3 | Prospectus | Jul 30, 2025 | — |
| 15-12G | Deregistration | Jul 30, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form s-3 | Jul 29, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form s-3 | Jul 29, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form s-3 | Jul 29, 2025 | — |
| POS AM | Post-effective amendment no. 2 to form f-3 on form s-3 | Jul 29, 2025 | — |
| POS AM | Post-effective amendment no. 3 to form f-3 on form s-3 | Jul 29, 2025 | — |
| S-8 POS | Registration statement | Jul 25, 2025 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Jul 25, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 16, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Dec 20, 2024 | Dec 19, 2024 |
| DEF 14A | Proxy statement | Nov 25, 2024 | Dec 19, 2024 |
| 8-K/A |
Amended current report
Material agreement, New debt
|
Nov 19, 2024 | Sep 26, 2024 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | Notification of late filing | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| PRE 14A | Preliminary proxy statement | Nov 12, 2024 | Nov 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 7, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Nov 6, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 5, 2024 | — |
| DEF 14A | Proxy statement | Oct 11, 2024 | Oct 31, 2024 |
| 25 | Filing | Oct 7, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 2, 2024 | — |
| PRE 14A | Preliminary proxy statement | Oct 1, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, New debt, Listing notice, Unregistered share sale, Other events
|
Oct 1, 2024 | Sep 26, 2024 |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 27, 2024 | Aug 23, 2024 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Jul 15, 2024 | Jul 15, 2024 |
| EFFECT | Filing | Jun 28, 2024 | — |
| 424B3 | Prospectus | Jun 28, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| S-3/A | Filing | Jun 26, 2024 | — |
| 8-K/A |
Amended current report
Auditor change
|
Jun 25, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 24, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Auditor change
|
Jun 24, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2024 | Jun 14, 2024 |
| S-3/A | Filing | Jun 14, 2024 | — |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2024 | Jun 7, 2024 |
| UPLOAD | Letter from the SEC | Jun 11, 2024 | — |
| S-3 | Shelf registration | Jun 5, 2024 | — |
| 3 | Initial insider ownership | Jun 5, 2024 | May 27, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 28, 2024 | May 24, 2024 |
| 424B5 | Prospectus supplement | May 15, 2024 | — |
| 8-K |
Current report
Material agreement
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 424B3 | Prospectus | May 8, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| 4 | Insider transaction | Apr 26, 2024 | Apr 24, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 26, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 26, 2024 | Apr 24, 2024 |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Shareholder vote results
|
Apr 23, 2024 | Apr 17, 2024 |
| S-3 | Shelf registration | Apr 17, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 9, 2024 | Apr 5, 2024 |
| 424B5 | Prospectus supplement | Apr 9, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2024 | Apr 8, 2024 |
| SC 13G | Ownership over 5% (passive) | Apr 4, 2024 | — |
| DEF 14A | Proxy statement | Mar 29, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 29, 2024 | Mar 28, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 21, 2024 | — |
| PRE 14A | Preliminary proxy statement | Mar 19, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 13, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 15, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Listing notice
|
Dec 29, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Dec 18, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Dec 18, 2023 | Dec 15, 2023 |
| DEFA14A | Additional proxy material | Dec 8, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2023 | Dec 5, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| 4 | Insider transaction | Nov 22, 2023 | Nov 20, 2023 |
| ARS | Annual report to shareholders | Nov 17, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| DEFR14A | Filing | Nov 13, 2023 | — |
| DEF 14A | Proxy statement | Nov 13, 2023 | Dec 15, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 3, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 24, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2023 | Oct 17, 2023 |
| EFFECT | Filing | Oct 6, 2023 | — |
| EFFECT | Filing | Oct 6, 2023 | — |
| EFFECT | Filing | Oct 6, 2023 | — |
| 10-K/A | Amended annual report | Oct 6, 2023 | Jun 30, 2023 |
| CORRESP | Letter to the SEC | Oct 5, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 3, 2023 | Oct 3, 2023 |
| RW WD | Filing | Oct 3, 2023 | — |
| CORRESP | Letter to the SEC | Oct 2, 2023 | — |
| RW | Filing | Oct 2, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2023 | — |
| CORRESP | Letter to the SEC | Sep 29, 2023 | — |
| 8-K |
Current report
Results of operations
|
Sep 28, 2023 | Sep 28, 2023 |
| S-3 | Shelf registration | Sep 28, 2023 | — |
| POS AM | Filing | Sep 28, 2023 | — |
| POS AM | Filing | Sep 28, 2023 | — |
| S-8 | Employee stock plan registration | Sep 28, 2023 | — |
| 10-K | Annual report | Sep 28, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2023 | Sep 22, 2023 |
| 3 | Initial insider ownership | Sep 12, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 21, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2023 | Jul 17, 2023 |
| 4 | Insider transaction | Jul 11, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 6, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 3, 2023 | Jul 1, 2023 |
| 3 | Initial insider ownership | Jul 3, 2023 | Jul 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 3, 2023 | Jul 3, 2023 |
| 6-K | Current report (foreign issuer) | Jun 30, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jun 9, 2023 | Jun 9, 2023 |
| 6-K | Current report (foreign issuer) | Jun 9, 2023 | Jun 9, 2023 |
| 6-K | Current report (foreign issuer) | May 22, 2023 | May 22, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| EFFECT | Filing | May 10, 2023 | — |
| 424B3 | Prospectus | May 10, 2023 | — |
| CORRESP | Letter to the SEC | May 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | May 2, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 30, 2023 | Mar 30, 2023 |
| 6-K | Current report (foreign issuer) | Mar 27, 2023 | Mar 27, 2023 |
| 6-K | Current report (foreign issuer) | Mar 21, 2023 | Mar 21, 2023 |
| 6-K | Current report (foreign issuer) | Mar 10, 2023 | Mar 10, 2023 |
| SC 13D | Ownership over 5% (active) | Feb 17, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13D | Ownership over 5% (active) | Feb 10, 2023 | — |
| 6-K | Current report (foreign issuer) | Feb 8, 2023 | Feb 8, 2023 |
| 6-K | Current report (foreign issuer) | Dec 20, 2022 | Dec 20, 2022 |
| 6-K | Current report (foreign issuer) | Nov 30, 2022 | Nov 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 29, 2022 | Nov 29, 2022 |
| 6-K | Current report (foreign issuer) | Nov 22, 2022 | Nov 22, 2022 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Oct 25, 2022 | Oct 25, 2022 |
| 6-K | Current report (foreign issuer) | Sep 21, 2022 | Sep 21, 2022 |
| 6-K | Current report (foreign issuer) | Aug 17, 2022 | Aug 17, 2022 |
| EFFECT | Filing | Aug 2, 2022 | — |
| POS AM | Filing | Aug 1, 2022 | — |
| 20-F/A | Amended annual report (foreign issuer) | Aug 1, 2022 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Jun 30, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jun 27, 2022 | Jun 27, 2022 |
| EFFECT | Filing | Jun 6, 2022 | — |
| 424B3 | Prospectus | Jun 6, 2022 | — |
| CORRESP | Letter to the SEC | Jun 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | May 27, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | May 27, 2022 | — |
| SC 13G | Ownership over 5% (passive) | May 27, 2022 | — |
| 6-K/A | Filing | Apr 29, 2022 | Apr 29, 2022 |
| 6-K | Current report (foreign issuer) | Apr 1, 2022 | Apr 1, 2022 |
| 6-K | Current report (foreign issuer) | Mar 31, 2022 | Mar 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2022 | — |
| CORRESP | Letter to the SEC | Jan 27, 2022 | — |
| 20-F/A | Amended annual report (foreign issuer) | Jan 27, 2022 | Jun 30, 2021 |
| UPLOAD | Letter from the SEC | Jan 24, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 20, 2021 | Dec 20, 2021 |
| 6-K | Current report (foreign issuer) | Dec 7, 2021 | Dec 7, 2021 |
| 6-K | Current report (foreign issuer) | Nov 30, 2021 | Nov 30, 2021 |
| 20-F | Annual report (foreign issuer) | Oct 21, 2021 | Jun 30, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- RNLXY (OTC), RENXF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1811115
- Former names
- Renalytix AI plc (until Jun 25, 2021)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.